Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis
- Conditions
- Streptococcal Infections
- Registration Number
- NCT00261742
- Lead Sponsor
- University Children's Hospital Basel
- Brief Summary
The goal of the study is to investigate, which of two antibiotic treatments - oral penicillin for 10 days or oral cefuroxim for 7 days - is more successful for patients (1-16 years of age) with perianal dermatitis caused by group A beta-hemolytic streptococci.
- Detailed Description
The goal of the study is to investigate, which of two antibiotic treatments - oral penicillin for 10 days or oral cefuroxim for 7 days - is more successful for patients (1-16 years of age) with perianal dermatitis caused by group A beta-hemolytic streptococci (GABHS). Diagnosis is based on positive perianal culture for GABHS. Informed consent will be obtained.
The study will be performed in the region of Basel, Switzerland, in private practices of pediatricians, general practitioners, and selected pediatric dermatologists as well as in the out-patient departments of the University Children's Hospital Basel and the department for dermatology of the University of Basel.
Patients (or their parents) will fill in a daily diary on signs and symptoms of disease; furthermore, clinical investigations (inspection of the site of infection) will be performed on enrollment (Day 1), Day 3, and at the end of treatment (Day 10).
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 194
- informed consent
- age 1-16 years
- typical clinical symptoms for perianal dermatitis
- positive perianal culture for GABHS
- antibiotic treatment in previous 14 days
- immunodeficiency
- penicillin allergy
- cephalosporin allergy
- further bacterial infections
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Resolving signs and symptoms of perianal dermatitis
- Secondary Outcome Measures
Name Time Method microbiological cure (= negative culture for GABHS) at end of treatment
Trial Locations
- Locations (1)
University Children's Hospital
🇨ðŸ‡Basel, Switzerland